Todd Pangburn
Todd Pangburn
@todd-p.bsky.social
Husband-Father-Scientist currently developing the Healthcare and BioPharma Processing technologies of tomorrow at DuPont. (All opinions are my own.)
12 followers19 following5 posts
Really good interview on the future of #celltherapies as we step into 2025. Jason Bock, CEO of CTMC, emphasized how the manufacturing platform is proportionately more important for cell therapies than with other therapies. www.cellandgene.com/doc/ctmc-s-c...
cellandgene.comCTMC's 2025 Cell Therapy Manufacturing Outlook<p>CEO Jason Bock looks back on milestones of 2024, namely an approved TIL for melanoma, and explains how it sets the stage for this year.</p>
You are up to date.